MedTrace Logo

Clinical Trial to Evaluate the Efficacy of a Probiotic Preparation in the Prevention of Upper Respiratory Tract Infections in Adults

NCT07091955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-08-22

No results posted yet for this study

Summary

Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy adult population

Conditions

  • URTI - Viral Upper Respiratory Tract Infection
  • Prevention

Interventions

DIETARY_SUPPLEMENT

Lacticaseibacillus rhamnosus CRL1505

Probiotic product containing Lacticaseibacillus rhamnosus CRL1505 formulated in a vegetable hydroxymethylpropyl-cellulose capsule of size 2

DIETARY_SUPPLEMENT

Placebo Comparator

Placebo product containing cornstarch, in a vegetable hydroxymethylpropyl-cellulose capsule of size 2

Sponsors & Collaborators

  • Centro Sperimentale del Latte S.r.l.

    collaborator UNKNOWN

  • Bioithas SL

    lead INDUSTRY

Principal Investigators

  • Valentina Taverniti, Microbes & Health R&D Leader · Centro Sperimentale del Latte S.r.l.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2024-02-27
Completion
2024-02-27

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07091955 on ClinicalTrials.gov